drugset
drugset / Trial / NCT01155960

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions

NCT01155960 ↗

Phase 1 Completed 36 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare bioavailability in healthy, post menopausal women subjects under fed conditions.

Timeline

Start
2008-05
Primary completion
2008-06
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg Oral

Indications

No indication recorded.